Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells (original) (raw)

References

1. Woolley DE, 1984, Collagenolytic mechanisms in tumor cell invasion.Cancer Metastasis Rev,3, 361–72.
   PubMed Google Scholar
2. Reich R, Thompson EW, Iwamoto YY,et al. 1988, Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells.Cancer Res,48, 3307–12.
   PubMed Google Scholar
3. Ossowski L, Clunie G, Masucci MT and Blasi F, 1991,In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion.J Cell Biol,115, 1107–1112.
   PubMed Google Scholar
4. Mackary AR, Corbitt RH, Hartzler JL and Thorgeirsson UP, 1990, Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases.Cancer Res,50, 5997–6001.
   PubMed Google Scholar
5. Declerck YA, Perez N, Shimada HH,et al. 1992, Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases.Cancer Res,52, 701–8.
   PubMed Google Scholar
6. Turpeenniemi HT, Thorgeirsson UP, Hart IR, Grant SS and Liotta LA, 1985, Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.JNCI,75, 99–103.
   PubMed Google Scholar
7. Nakajima M, Welch DR, Belloni PN and Nicolson GL, 1987, Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.Cancer Res,47, 4869–76.
   PubMed Google Scholar
8. Baker MS, Bleakley P, Woodrow GC and Doe WF, 1990, Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation.Cancer Res,50, 4676–84.
   PubMed Google Scholar
9. Lyons RM, Gentry LE, Purchio AF and Moses HL, 1990, Mechanism of activation of latent recombinant transforming growth factor beta-1 by plasmin.J Cell Biol,110, 1361–7.
   PubMed Google Scholar
10. Giangaspero F and Burger PC, 1983, Correlations between cytologic composition and biologic behaviour in the glioblastoma multiforme. A postmortem study of 50 cases.Cancer,52, 2320–33.
    PubMed Google Scholar
11. Laerum OD, Bjerkvig R, Steinsvag SK and Steinsvag de RL, 1984, Invasiveness of primary brain tumors.Cancer Metastasis Rev,3, 223–36.
    PubMed Google Scholar
12. Lund JM, Engebraaten O, Bjerkvig R and Laerum OD, 1990, Invasive glioma cells in tissue culture.Anticancer Res,10, 1135–51.
    PubMed Google Scholar
13. DE Ridder L, Laerum OD, Mork SJ and Bigner DD, 1987, Invasiveness of human glioma cell lines_in vitro_: Relation to tumorigenicity in athymic mice.Acta Neuropathologica,72, 207–13.
    PubMed Google Scholar
14. Sitrin RG, Gyetko MR, Kole KL, McKeever P and Varani J, 1990, Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines.Cancer Res,50, 4957–61.
    PubMed Google Scholar
15. Sawaya R, Ramo OJ, Shi ML and Mandybur G, 1991, Biological significance of tissue plasminogen activator content in brain tumors.J Neurosurgery,74, 480–6.
    Google Scholar
16. Murphy P and Hart DA, 1992, Modulation of plasminogen activator and plasminogen activator inhibitor expression in the human U373 glioblastoma/astrocytoma cell line by inflammatory mediators.Exp Cell Res,198, 93–100.
    PubMed Google Scholar
17. Stetler-Stevenson W, Krutzsch HC and Liotta LA, 1989, Tissue inhibitor of metalloproteinases (TIMP-2). A new member of the metalloproteinase inhibitor family.J Biol Chem,264, 17374–8.
    PubMed Google Scholar
18. Vaithilingram IS, Stroude EC, Mcdonald W and Del Maesrto RF, 1991, General protease and collagenase (IV) activity in C6 astrocytoma cells, C6 spheroids and implanted C6 spheroids.J Neuro-Oncol,10, 203–12.
    Google Scholar
19. Abe T, Okamura K, Ono M,et al. 1993, Induction of vascular endothelial tubular morphogenesis by human glioma cells: a model system for tumor angiogenesis.J Clin Invest,92, 54–61.
    PubMed Google Scholar
20. Welch DR, Bisi JE, Miller BE,et al. 1991, Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line.Int J Cancer,47, 227–37.
    PubMed Google Scholar
21. Mizoguchi H, Uchiumi T, Ono M, Kohno K and Kuwano M, 1990, Enhanced production of tissuetype plasminogen activator by estradiol in a novel type variant of human breast cancer MCF-7 cell line.Biochim Biophys Acta,1052, 475–82.
    PubMed Google Scholar
22. Mizoguchi H, Komiyama S, Matsui K,et al. 1991, The response to epidermal growth factor of human maxillary tumor cells in terms of tumor growth, invasion and expression of proteinase inhibitors.Int J Cancer,49, 738–43.
    PubMed Google Scholar
23. Nakayama Y, Kohno K, Nomura Y,et al. 1993, Enhanced invasive activity and decreased expression of tissue inhibitors of metalloproteinases by hepatocyte growth factor in human renal cancer cells.Cancer J,6, 213–19.
    Google Scholar
24. Mawatari M, Kohno K, Mizoguchi H,et al. 1989, Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells.J Immunol,143, 1619–27.
    PubMed Google Scholar
25. Mawatari M, Okamura K, Matsuda T,et al. 1991, Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor.Exp Cell Res,192, 574–88.
    PubMed Google Scholar
26. Erkell LJ and Schirrmacher V, 1988, Quantitative_in vivo_ assay for tumor cell invasion through extracellular matrix or into protein gels.Cancer Res,48, 6933–7.
    PubMed Google Scholar
27. Goldberg GI, Marmer BL, Grant GA,et al. 1989, Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.Proc Natl Acad Sci USA,86, 8207–11.
    PubMed Google Scholar
28. Sato H, Kida Y, Mai M,et al. 1992, Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells.Oncogene,7, 77–83.
    PubMed Google Scholar
29. Gross JL, Behrens DL and Mullins DE, 1988, Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.Cancer Res,48, 291–6.
    PubMed Google Scholar
30. Nielsen LS, Hansen JG, Skriver L,et al. 1982, Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.Biochemistry,21, 6410–15.
    PubMed Google Scholar
31. Paganetti PA, Caroni P and Schwab ME, 1988, Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease.J Cell Biol,107, 2281–91.
    PubMed Google Scholar
32. Mareel MM, 1983, Invasion_in vitro_. Methods of analysis.Cancer Metastasis Rev,2, 201–18.
    PubMed Google Scholar
33. Moscatelli D and Rifkin DB, 1988, Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis.Biochim Biophys Acta,948, 67–85.
    PubMed Google Scholar
34. Laiho M and Keski OLJ, 1990, Growth factors in the regulation of pericellular proteolysis: a review.Cancer Res,49, 2533–53.
    Google Scholar
35. Haward EW, Bullen EC and Banda MJ, 1991, Preferential inhibition of 72 and 92 kDa gelatinases by tissue inhibitor of metalloproteinases-2.J Biol Chem,266, 13070–5.
    PubMed Google Scholar

Download references